Kolexia
Delette Caroline Hématologie
Delette Caroline
Hématologie
Centre Hospitalier D'Amiens Salouël Site Sud
Salouël, France
77 Activités
196 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Lymphome B diffus à grandes cellules Lymphome T Myélome multiple Syndromes myélodysplasiques Lymphome à cellules du manteau Aspergillose Leucémies

Collaborateurs

Voir plus
Marolleau Jean Pierre
Marolleau Jean Pierre
Centre Hospitalier D'Amiens Salouël Site Sud, Salouël, France
Casasnovas Rene-Olivier
Casasnovas Rene-Olivier
Hôpital François Mitterrand, Dijon, France
Thieblemont Catherine
Thieblemont Catherine
Hôpital Saint-Louis, Paris, France
Le Gouill Steven
Le Gouill Steven
Clcc Institut Curie, Paris, France

Industries

Voir plus
Abbvie
16 collaboration(s)
Dernière en 2023
AstraZeneca
5 collaboration(s)
Dernière en 2023
Janssen
5 collaboration(s)
Dernière en 2023
B3TSI
4 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
LOC-R01: Randomized Phase IB/II Study of Escalating Doses of Lenalidomide and Ibrutinib in Association With R-MPV as a Targeted Induction Treatment for Patients Aged 18 to 60 (up to 65 for Phase II) With a Newly Diagnosed Primary Central Nervous System Lymphoma
Essai Clinique (Institut Curie)   10 janvier 2024
GLORIFY: A Phase 2 Study Evaluating the Bispecific CD3xCD20 Antibody GLOfitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (CHOP) in Patients With RIchter Syndrome as Frontline therapY
Essai Clinique (Roche)   29 décembre 2023
Correction to: Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B‑cell lymphoma: results of a multicentric prospective cohort study.
Annals of hematology   26 octobre 2023
TRANSCRIPT: Transplantation After Complete Response In Patients With T-cell Lymphoma
Essai Clinique (Hospices Civils de Lyon)   26 septembre 2023
Flow cytometry as a fast, cost-effective tool to assess IGHV mutational status in CLL.
Blood advances   24 août 2023
Brigatinib in patients with ALK-positive anaplastic large cell lymphoma who have failed brentuximab vedotin
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Relyage: Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma
Essai Clinique (CHU Amiens-Picardie)   07 février 2023
PAMAL: Physical Exercises for Patient Undergoing Hematopoietic Stem Cell Transplantation for Multiple Myeloma: a Controlled Randomised Prospective Multicentre Longitudinal Study.
Essai Clinique (CHU Amiens-Picardie)   07 février 2023
The ALK-OBS Trial: Results of a Multicenter Prospective Study Assessing the Prognostic Value of New Markers in Adults with ALK-Positive ALCL Treated By CHOEP: A Lysa Study
Annual Meeting Abstracts 2022   15 novembre 2022
Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"
Annual Meeting Abstracts 2022   15 novembre 2022